Agrochemical Net Chinese website reported: Recently, Syngenta's new seed
4.17 World Tumor Day Lymphoma Cases | The small inconspicuous lump on the baby's neck, grow up a little bit, parents must pay attention!
Time of Update: 2021-04-22
April 17
April 17Global feed market: seeding concerns, feed prices mostly rise
Time of Update: 2021-04-22
News from April 18th: In the week ending April 16, 2021, most
base for the drug consortium ensures the supply of small varieties of drugs
Time of Update: 2021-04-22
Small-species medicines (shortage medicines) are urgently needed life-saving medicines for some patients.
However
Daily review of bisphenol A: a small finishing
Time of Update: 2021-04-21
On the last trading day (February 17), the mainstream transaction price in the East China region of the mainstream market temporarily formed a range of 20,100 to 20,300 yuan/ton, with a low-key increase of 100 yuan/ton.
Daily review of bisphenol A: a small drop in the interval
Time of Update: 2021-04-20
On the trading day (August 01, 2011), the amount of bisphenol A raw materials can increase (slightly, see the full version for details).
The Dilemma and Outlet of Small Molecule Drugs
Time of Update: 2021-04-19
It is mainly the discovery of new targets and disease indications that promote breakthroughs in the research and development of small molecule drugs.
The annual "star" small molecule list is released, including long-acting HIV therapy, PROTAC molecules, KRAS inhibitors...
Time of Update: 2021-04-19
. Therefore, this list reflects the evaluation of small molecule drugs under research by industry experts. The voting results showed that Gilead Sciences
-
-
-
-
The annual "star" small molecule list is released, including long-acting HIV therapy, PROTAC molecules...
Time of Update: 2021-04-19
The voting results showed that Gilead Sciences' long-acting HIV capsid inhibitor lenacapavir (GS-6207) ranked first, and GlaxoSmithKline (GSK)'s targeted protein degrading agent PROTAC to degrade RIPK2 protein was ranked 6th.
BridGene, a small molecule drug developed for the "unable to drug" target, reached a cooperation with Takeda
Time of Update: 2021-04-19
new drug discovery projects, using BridGene's proprietary IMTAC chemical proteomics platform to discover new targets and small molecule drug candidates for Takeda, and Takeda will advance these drug candidates into the clinical development stage
Microchip's "Cioroni Capsule" launches Phase III clinical trial for small cell lung cancer
Time of Update: 2021-04-18
Recently, the Insight database revealed that Microchip Bio-Sioroni Capsules has launched a Phase III clinical trial for the treatment of small cell lung cancer that has progressed or recurred after a 2-line system of chemotherapy.
Going ahead, further opportunities and challenges for the development of oral PD-L1 small molecule inhibitors
Time of Update: 2021-04-18
-space:normal;"> PD-1/PD-L1 monoclonal antibody drugs form a tens of billions of commercial market >
-
Biological agents or small molecule dual therapy: a new strategy for the treatment of "refractory inflammatory bowel disease" | Research Express
Time of Update: 2021-04-18
Therefore, Clin Gastroenterol Hepatol recently published a systematic review and meta-analysis aimed at evaluating the safety and effectiveness of dual biologic therapy or combination therapy with tofacitinib in patients with refractory IBD.
1 minute self-test, 5 small questions about the diagnosis and treatment of diabetic nephropathy (1) | Clear the "Secret" language
Time of Update: 2021-04-18
-choice questions. The content is mainly based on authoritative guides/consensus at home and abroad. References or links to related articles will be marked in the analysis part for everyone to review and review.
-
-
-
-
-
-
Professor Han Baohui: Atelizumab is expected to become a new choice for the first-line treatment of advanced non-small cell lung cancer
Time of Update: 2021-04-18
S. Food and Drug Administration (FDA) with the success of the IMpower110 study Atilizumab is the first-line treatment for patients with metastatic NSCLC with high PD-L1 expression (TC≥50% or IC≥10%) [1].
BeiGene Announces Global Phase 3 Clinical Interim Analysis Results of Baizean® in the Treatment of Second- and Third-Line Non-Small Cell Lung Cancer
Time of Update: 2021-04-18
On April 13, BeiGene (Nasdaq code: BGNE; Hong Kong Stock Exchange code: 06160) announced its anti-PD-1 antibody Bazeran® at the American Association for Cancer Research (AACR) 2021 annual meeting (Tilelizumab
Soybean seed coat color formation mechanism revealed
Time of Update: 2021-04-17
Experimental analysis results show that GmMYBA2 can interact with the bHLH transcription factor GmTT8a to directly activate the expression of genes related to anthocyanin synthesis in soybeans.
More than 10,000 wild plant seeds "sleep" here
Time of Update: 2021-04-17
, there is a low-key and mysterious "national weapon"-the Southwest China Wildlife Germplasm Bank, also known as the "Noah's Ark" of my country's wildlife. > In the seed management laboratory
Using highly hydrogenated soybean oil, camphor seed oil and perilla oil to prepare zero-trans
Time of Update: 2021-04-17
/LPL, SOO/OSO, LOO/OLO and POS content has increased. 2) Measure the solid fat content (SFC) by nuclear magnetic resonance (NMR) and determine the sliding melting point (SMP) according
with chemotherapy as a neoadjuvant treatment for patients with resectable non-small cell lung cancer can significantly improve tumor pathology and complete remission
Time of Update: 2021-04-17
="s2">) in the form of the first public release. >CheckMate -816 is the first randomized,
Welcome to Echemi
